Wellington Management Group

Wellington Management Group’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Wellington Management Group’s Portfolio TCRR Stock Details TCRR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-835,327	Closed	-$3.89M	–	2290
2021 Q4	$3.89M	Sell	835,327 -1,909,849	-70%	-$11.9M	﹤0.01%	1523
2021 Q3	$23.4M	Sell	2,745,176 -2,589,162	-49%	-$36.6M	﹤0.01%	1050
2021 Q2	$87.5M	Buy	5,334,338 +398,244	+8%	+$8.04M	0.01%	669
2021 Q1	$109M	Buy	4,936,094 +1,182,730	+32%	+$32.2M	0.02%	595
2020 Q4	$116M	Buy	3,753,364 +1,762,274	+89%	+$44.6M	0.02%	552
2020 Q3	$40.5M	Buy	+1,991,090	New	+$35M	0.01%	753

Other funds holding TCRR

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return